AXIM BIOTECHNOLOGIES, INC. Accretion Expense
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Accretion Expense of $32.94 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2022-05-23
- AXIM BIOTECHNOLOGIES, INC. accretion expense for the quarter ending 2022-03-31 was $32.94K.
- AXIM BIOTECHNOLOGIES, INC. accretion expense for the quarter ending 2017-12-31 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. accretion expense for the quarter ending 2016-12-31 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. accretion expense for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- AXIM BIOTECHNOLOGIES, INC. accretion expense for fiscal 2016 was $212.50K.
| Period end | Accretion Expense 3 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|
| 2022-03-31 | $32.94K 10-Q · filed 2022-05-23 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-22 | ||
| 2020-09-30 | $51.41K 10-Q · filed 2021-11-22 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 10-K · filed 2018-03-15 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-20 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $212.50K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $212.50K 10-Q · filed 2017-11-20 |